Lisanti Capital Growth’s MiMedx Group MDXG Stock Holding History

Lisanti Capital Growth’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-56,845	Closed	-$675K	–	122
2017 Q3	$675K	Sell	56,845 -4,780	-8%	-$70.9K	0.42%	88
2017 Q2	$923K	Buy	+61,625	New	+$822K	0.61%	73
2017 Q1	–	Sell	-33,440	Closed	-$296K	–	99
2016 Q4	$296K	Buy	+33,440	New	+$300K	0.36%	88
2016 Q2	–	Sell	-62,860	Closed	-$549K	–	104
2016 Q1	$549K	Buy	+62,860	New	+$522K	0.65%	76
2015 Q4	–	Sell	-104,204	Closed	-$1.01M	–	97
2015 Q3	$1.01M	Sell	104,204 -28,681	-22%	-$303K	0.91%	54
2015 Q2	$1.54M	Buy	132,885 +12,445	+10%	+$128K	1.11%	47
2015 Q1	$1.25M	Sell	120,440 -94,936	-44%	-$889K	0.71%	76
2014 Q4	$2.48M	Sell	215,376 -24,864	-10%	-$246K	1.24%	34
2014 Q3	$1.71M	Buy	240,240 +157,855	+192%	+$1.1M	0.86%	55
2014 Q2	$584K	Buy	+82,385	New	+$482K	0.26%	91
2014 Q1	–	Sell	-284,480	Closed	-$2.49M	–	117
2013 Q4	$2.49M	Buy	+284,480	New	+$1.74M	1.05%	45

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Lisanti Capital Growth's MDXG Position: Q4 2017 in Review

Lisanti Capital Growth sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 56,845 shares — an estimated $675K sold.

Lisanti Capital Growth first reported a position in MDXG in Q4 2013 and held it in 11 quarters. The position peaked at $2.49M in Q4 2013. 236 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

Lisanti Capital Growth reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
Lisanti Capital Growth sold 56,845 MiMedx Group shares in Q4 2017, an estimated $675K.
Lisanti Capital Growth first reported a position in MiMedx Group in Q4 2013 and held it in 11 quarters.
Lisanti Capital Growth's MiMedx Group position peaked at $2.49M in Q4 2013.
236 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on Lisanti Capital Growth's 13F filing for Q4 2017, filed 7 Feb 2018.